Why is Suven Life Scie. falling/rising?

As of 30-Jul, Suven Life Sciences Ltd is experiencing a decline in its stock price, currently at Rs 271.20, reflecting a decrease of Rs 10.8 or 3.83%. Today's price summary indicates that the stock has underperformed its sector by 4.17%, with an intraday low of Rs 269, which is a drop of 4.61%. The stock has shown a mixed performance over various periods, with a notable 88.99% increase over the past year, yet it has also faced significant challenges, including operating losses and a negative EBITDA. The company's long-term fundamentals appear weak, as evidenced by a substantial decline in net sales and operating profit over the last five years, alongside three consecutive quarters of negative results.
In the broader market context, the stock's short-term performance has been notably worse than the benchmark, with a 1-week return of -5.83% compared to the Sensex's -1.50%. While the stock has outperformed the BSE500 over the long term, its recent struggles, including a significant drop in investor participation and liquidity concerns, have contributed to its current price decline. The combination of poor financial health indicators, such as a negative EBIT to interest ratio and declining profitability, suggests that the stock's recent downturn is driven by both company-specific issues and a challenging market environment.